NDC 70771-1086

oxybutynin

Oxybutynin

oxybutynin is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Oxybutynin Chloride.

Product ID70771-1086_0dc00bfe-5c56-444c-87c0-9511deec2414
NDC70771-1086
Product TypeHuman Prescription Drug
Proprietary Nameoxybutynin
Generic NameOxybutynin
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2017-08-10
Marketing CategoryANDA / ANDA
Application NumberANDA202332
Labeler NameCadila Healthcare Limited
Substance NameOXYBUTYNIN CHLORIDE
Active Ingredient Strength5 mg/1
Pharm ClassesCholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70771-1086-1

100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-1)
Marketing Start Date2017-08-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70771-1086-5 [70771108605]

oxybutynin TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202332
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-10

NDC 70771-1086-1 [70771108601]

oxybutynin TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202332
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-10

NDC 70771-1086-3 [70771108603]

oxybutynin TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202332
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-10

NDC 70771-1086-9 [70771108609]

oxybutynin TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202332
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-10

NDC 70771-1086-4 [70771108604]

oxybutynin TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202332
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-10

NDC 70771-1086-2 [70771108602]

oxybutynin TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202332
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-10

NDC 70771-1086-6 [70771108606]

oxybutynin TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202332
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-10

Drug Details

Active Ingredients

IngredientStrength
OXYBUTYNIN CHLORIDE5 mg/1

OpenFDA Data

SPL SET ID:f405a774-bd91-4513-b7c7-c44f0596d988
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 863628
  • 863636
  • 863619

    • Pharmacological Class

    • Cholinergic Muscarinic Antagonist [EPC]
    • Cholinergic Muscarinic Antagonists [MoA]

    NDC Crossover Matching brand name "oxybutynin" or generic name "Oxybutynin"

    NDCBrand NameGeneric Name
    0615-8219oxybutyninoxybutynin
    0615-8220OxybutyninOxybutynin
    50090-5352oxybutyninoxybutynin
    50090-5353oxybutyninoxybutynin
    68382-255oxybutyninoxybutynin
    68382-256oxybutyninoxybutynin
    68382-257oxybutyninoxybutynin
    70518-1457oxybutyninoxybutynin
    70518-2331oxybutyninoxybutynin
    70771-1086oxybutyninoxybutynin
    70771-1087oxybutyninoxybutynin
    70771-1088oxybutyninoxybutynin
    71335-0974oxybutyninoxybutynin
    0023-6153OXYTROLOxybutynin
    52544-920OXYTROLOxybutynin
    0023-9637Oxytrol for WomenOxybutynin
    52544-166Oxytrol For Womenoxybutynin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.